Autres langues Torrent Pharmaceuticals Limited NSE India S.E.

Actions

TORNTPHARM

INE685A01028

Produits pharmaceutiques

Marché Fermé - NSE India S.E. 13:05:10 05/10/2026			Varia. 5j.	Varia. 1 janv.
4 772,00 ^INR	+0,10%		-4,34%	+23,95%

28/09	Torrent Pharma paiera davantage pour sa participation de 26 % dans son unité énergétique après la modification de l’accord	MT
28/09	Torrent Pharmaceuticals Limited augmente son investissement dans Torrent Urja 27 Private Limited pour un projet hybride d’électricité en autoconsommation au Gujarat	CI

Autres langues

28/09	Torrent Pharma to Pay More for its 26% Stake in Power Unit After Amending Agreement
28/09	Torrent Pharmaceuticals Limited Enhances Investment in Torrent Urja 27 Private Limited for Captive Hybrid Power Project in Gujarat
08/09	India's Torrent Gas files updated IPO papers
30/07	Torrent Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
30/07	Torrent Pharmaceuticals Limited Announces Management Changes, Effective July 30, 2026
30/07	Torrent Pharmaceuticals Limited Announces Term Completion of Ameera Shah as Independent Director, Effective August 1, 2026
16/07	Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges
09/07	India's Dr Reddy's says semaglutide shipping disruption to last until at least late October
09/07	India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice
09/07	Torrent Pharmaceuticals Limited Implements Voluntary Recall for Select Batches of Semalix Injection Disposable Pens
23/06	Torrent Pharmaceuticals Limited Approves Final Dividend for the Financial Year Ended 31 March, 2026
22/05	Torrent Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
22/05	Indian drugmaker Torrent Pharma posts lower quarterly profit on acquisition costs
22/05	Torrent Pharmaceuticals Limited Recommends Final Dividend, Payable on or Around 25 June 2026
06/05	Algorae Pharmaceuticals executes license & supply agreement with Torrent Pharma
10/04	Torrent Pharma says USFDA inspected its Bileshwarpura (oncology) facility from 06-Apr-26 to 10-Apr-26
23/03	Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy
21/03	Torrent Pharma says to launch generic oral semaglutide in India
21/03	Torrent Pharmaceuticals Limited Launches Oral and Injectable Formulations of Semaglutide
18/03	Zydus Lifesciences Limited And Torrent Pharmaceuticals Limited Sign Licensing Agreement To Co-Market Semaglutide Injection In India
05/03	Sattrix Bags Work Orders Worth Over INR13 Million for Cyber Security Services
27/02	Xeris Biopharma Sues Torrent Pharmaceuticals, Somerset Therapeutics Over Recorlev Patents
27/02	Xeris Biopharma subsidiaries file Recorlev patent infringement lawsuit
13/02	Torrent Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
13/02	Torrent Pharma Q3 consol net profit 6.35 billion rupees